| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524679 Methods for culturing human lung mast cells and uses thereof |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524509 Proteosome-liposaccharide vaccine adjuvant |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | CA2446944C Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2344686C High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/28/2009 | CA2283537C Vectors having enhanced expression, and methods of making and uses thereof |
| 04/28/2009 | CA2219988C Cd16-ii variants |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/23/2009 | WO2009052293A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | WO2009052090A2 Silicate containing compositions and methods of treatment |
| 04/23/2009 | WO2009052081A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | WO2009050742A1 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method |
| 04/23/2009 | WO2009050390A2 Method for producing flu virus |
| 04/23/2009 | WO2009050258A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/23/2009 | WO2009050204A1 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 04/23/2009 | WO2009050159A1 Combination of fluticasone furoate with 4- [ (4-chl0r0phenyl)methyl] -2- ({ (2r)-i- [4-(4-{ [3-(hexahydr0-lh-azepin-l-yl) propyl ] oxy} phenyl) butyl] -2-pyrrolidinyl}methyl) -1 (2h) - phthalaz inone |
| 04/23/2009 | WO2009049365A1 A method of prophylaxis and agents for use therein |
| 04/23/2009 | WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/23/2009 | WO2009011889A4 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2008134659A8 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 04/23/2009 | WO2007009064A3 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105351 Micellar drug delivery systems for hydrophobic drugs |
| 04/23/2009 | US20090105342 Pufa supplements |
| 04/23/2009 | US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 04/23/2009 | US20090105315 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105295 Hydroxylamine substituted imidazoquinolines |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105225 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/23/2009 | US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104618 Diagnosing high grade ductal carcinoma (mammary glands) in situ (DCIS) by determining the level of psoriasin gene expression in a sample |
| 04/23/2009 | US20090104286 Regulation of allergic reaction |
| 04/23/2009 | US20090104271 Use of microparticles combined with submicron oil-in-water emulsions |
| 04/23/2009 | US20090104268 Nanoparticles Comprising Antigens and Adjuvants, and Immunogenic Structures |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104224 Modified vaccinia virus ankara for the vaccination of neonates |
| 04/23/2009 | US20090104223 Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations |
| 04/23/2009 | US20090104217 Pharmaceutical Composition Comprising An Antigen |
| 04/23/2009 | US20090104212 Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
| 04/23/2009 | US20090104208 House Dust Mite Allergen |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104190 Humanized anti-cd4 antibody with immunosuppressive properties |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104142 Compositions for treating multiple sclerosis |
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | CA2702572A1 Tr1 cells, mesenchymal stem cells and uses thereof |
| 04/23/2009 | CA2702473A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | CA2702307A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/23/2009 | CA2701329A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | CA2700288A1 Method for producing flu virus |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050465A2 Compositions comprising the adjuvant QS-21 and polysorbate or cyclodextrin as excipient |
| 04/22/2009 | EP2050455A1 Compounds leading to an increase of the IL-12/IL-10 ratio and their use for therapy of infectious and proliferative diseases |
| 04/22/2009 | EP2049516A2 Pharmaceutical compounds |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049122A1 Methods and compositions for inhibiting angiogenesis |
| 04/22/2009 | EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1830861B1 Antiviral and immunostimulating marine fish oil composition |
| 04/22/2009 | EP1598079B1 Remedies for allergic contact dermatitis |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1424387B1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | EP1181319B1 Chimeric dr4 antibodies and uses thereof |
| 04/22/2009 | EP1090039B1 Peptide composition as immunogen for the treatment of allergy |
| 04/22/2009 | EP1089757B1 Hla binding peptides and their uses |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101415432A A pharmaceutical composition useful as an immunomodulating agent and a process for the preparation thereof |
| 04/22/2009 | CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 04/22/2009 | CN101415408A Milk oligosaccharides for stimulating immune system |
| 04/22/2009 | CN101412959A Medical liquor |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 04/22/2009 | CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof |
| 04/22/2009 | CN101411875A Preparation for preparing pig serum immunoglobulin long-acting dosage form |
| 04/22/2009 | CN101411874A Preparation for preparing dog serum immunoglobulin long-acting dosage form |
| 04/22/2009 | CN101411871A Method for preparing chicken thymosin long-acting dosage form |
| 04/22/2009 | CN101411867A Method for preparing chicken interleukin-2 long-acting dosage form |
| 04/22/2009 | CN101411864A Thymopentin dry powder formulation and preparation method thereof |
| 04/22/2009 | CN101411778A Chinese medicine effective component composition and method for preparing the same |